Conclusions
ICE-guided pulmonary vein antrum isolation seems to prevent cerebrovascular accidents in patients with symptomatic drug-refractory AF who are not receiving anticoagulation therapy. ICE-guided pulmonary vein antrum isolation is an effective and safe treatment for AF.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wolf PA, Dawber TR, Thomas HE et al (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28:973–977
Flegel KM, Shipley MJ, Rose G (1987) Risk of stroke in non rheumatic atrial fibrillation. Lancet 1:526–529
Man-Son-Hing M, Laupacis A, O’Connor AM et al (1999) A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 282:737–743
Petersen P, Boysen G, Godtfredsen J et al (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1:175–179
Anonymous (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
Anonymous (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 323:1505–1511
Anonymous (1991) Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 84:527–539
Anonymous (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343:687–691
Haïssaguerre M, Jaïs P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666
Chen SA, Hsieh MH, Tai CT et al (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879–1886
Marrouche NF, Martin DO, Wazni O et al (2003) Phased array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 107:2710–2716
Evans A, Perez I, Yu G et al (2000) Secondary stroke prevention in atrial fibrillation. Stroke 32:2106–2111
Evans A, Perez I, Yu G et al (2001) Should stroke subtype influence anticoagulation decision to prevent recurrence in stroke patients with atrial fibrillation? Stroke 32:2828–2832
Lightowlers S, McGuire A (1998) Cost-effectiveness of anticoagulation in non rheumatic atrial fibrillation in the primary prevention of ischemic stroke. Stroke 29:1827–1832
Connolly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18:349–355
Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 327:1406–1412
Hart RG, Benavente O, McBride R (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492–501
Hart RG, Pearce LA, McBride R et al (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 30:1223–1229
Hart RG, Halperin JL, Pearce LA et al (2003) Stroke Prevention in Atrial Fibrillation Investigators. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med 138:831–838
Sherman DG, Kim SG, Boop BS et al; National Heart, Lung, and Blood Institute AFFIRM Investigators (2005) Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med 165:1185–1191
Go AS, Hylek EM, Philipps KA et al (2000) Implication of stroke risk criteria on the anticoagulation decision in non valvular atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA study). Circulation 102:11–13
De Piccoli B, Rigo F, Ragazzo M et al (2001) Transthoracic and transesophageal echocardiographic indices predictive of sinus rhythm maintenance after cardioversion of atrial fibrillation. Echocardiography 18:545–552
Gage BF, van Walraven C, Pearce L et al (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110:2287–2292
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Rossillo, A., Bonso, A., Themistoclakis, S., Corrado, A., De Piccoli, B., Raviele, A. (2006). Complications of Atrial Fibrillation Ablation: How to Prevent and Manage Cerebrovascular Accidents. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_31
Download citation
DOI: https://doi.org/10.1007/88-470-0371-7_31
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0370-5
Online ISBN: 978-88-470-0371-2
eBook Packages: MedicineMedicine (R0)